Literature DB >> 8722839

Is vulvovaginal candidiasis an AIDS-related illness?

M H White1.   

Abstract

Early in the AIDS epidemic, retrospective studies reported that vaginal candidiasis occurred more frequently in women who were infected with human immunodeficiency virus (HIV) than in those who were not infected. Some investigators suggested that new onset or recurrent vaginal candidiasis might identify HIV-infected individuals and predict the course of AIDS in women already known to be infected. In this article, studies of vaginal candidiasis in HIV-infected women are examined, and several observations are made. First, early studies were small and likely reflected biased populations. Second, adherence to previously accepted diagnostic criteria for vaginal candidiasis was not consistent in these studies. Finally, conclusions about the increased risk of recurrent or chronic candidal vaginitis in HIV-infected women have been promulgated in the medical literature and may have influenced clinical practice even though such statements are not supported epidemiologically. Prospective trials with uninfected community controls should determine the true impact of HIV infection on vulvovaginal candidiasis.

Entities:  

Mesh:

Year:  1996        PMID: 8722839     DOI: 10.1093/clinids/22.supplement_2.s124

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Induction of secretory aspartyl proteinase of Candida albicans by HIV-1 but not HSV-2 or some other microorganisms associated with vaginal environment.

Authors:  Ilknur Tosun; Faruk Aydin; Neşe Kaklikkaya; Murat Erturk
Journal:  Mycopathologia       Date:  2005-02       Impact factor: 2.574

Review 2.  Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Authors:  Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  Cytokine       Date:  2011-12-17       Impact factor: 3.861

Review 3.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 4.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

5.  Immune Regulation and Its Role in the Pathogenesis of Candida Vaginitis.

Authors:  Paul L. Fidel
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

Review 6.  Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: "Neutrophil Anergy".

Authors:  Junko Yano; Brian M Peters; Mairi C Noverr; Paul L Fidel
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

7.  Determinants of incident vulvovaginal candidiasis in human immunodeficiency virus-positive women.

Authors:  E Shifrin; D Matityahu; J Feldman; H Minkoff
Journal:  Infect Dis Obstet Gynecol       Date:  2000

8.  Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome.

Authors:  Vincent M Bruno; Amol C Shetty; Junko Yano; Paul L Fidel; Mairi C Noverr; Brian M Peters
Journal:  MBio       Date:  2015-04-21       Impact factor: 7.867

9.  Recurrent Vulvovaginal Candidiasis: Could It Be Related to Cell-Mediated Immunity Defect in Response to Candida Antigen?

Authors:  Zahra Talaei; Saba Sheikhbahaei; Vajihe Ostadi; Mazdak Ganjalikhani Hakemi; Mohsen Meidani; Elham Naghshineh; Majid Yaran; Alireza Emami Naeini; Roya Sherkat
Journal:  Int J Fertil Steril       Date:  2017-08-27

Review 10.  Recurrent Vulvovaginal Candidiasis: An Immunological Perspective.

Authors:  Diletta Rosati; Mariolina Bruno; Martin Jaeger; Jaap Ten Oever; Mihai G Netea
Journal:  Microorganisms       Date:  2020-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.